[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Divi's Laboratories Limited
Divi's Laboratories shares are facing mixed reactions due to a patent setback, despite positive news from HSBC and strong Q4 results. The stock is trading with a mix of positive and negative sentiment.
About Divi's Laboratories Limited
Divi's Laboratories Limited is a pharmaceutical company specializing in drug components.
Insights #
- Divi's Laboratories Limited creators is up XXXXXX% from the previous year.
- Divi's Laboratories Limited mentions is up XXXXXX% from the previous year.
Price: $ #
Price 24-Hour Chart Data
The price is likely experiencing mixed reactions due to the HSBC upgrade to 'Buy', positive social sentiment, and strong Q4 results, despite the recent patent setback and downgrade.
1-Year High: $XXXXXXXX on 2025-07-09
1-Year Low: $XXXXXXXX on 2024-07-23
AltRank: undefined #
AltRank 24-Hour Chart Data
Divi's Laboratories Limited is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXX
1-Year High: XXXXX on 2024-11-21
1-Year Low: XXX on 2024-08-04
Galaxy Score: XX #
Galaxy Score 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-01-02
1-Year Low: XX on 2024-11-02
Engagements: XXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX +77%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2025-02-17
1-Year Low: X on 2024-10-19
| Social Network | X | YouTube | |
|---|---|---|---|
| Engagements | X | XXXXX | XXX |
Mentions: XX #
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX +18%
1 Month: XXX +31%
6 Months: XXX +38%
1 Year: XXXXX +128%
1-Year High: XXX on 2025-07-10
1-Year Low: X on 2024-07-25
| Social Network | X | YouTube | |
|---|---|---|---|
| Mentions | X | XX | XX |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Divi's Laboratories Limited in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX +17%
1 Month: XXX +18%
6 Months: XXX +29%
1 Year: XXX +116%
1-Year High: XX on 2025-05-17
1-Year Low: X on 2024-07-25
The most influential creators that mention Divi's Laboratories Limited in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @raghavwadhwa | X | XXXXXX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% -XX%
6 Months: XX% +40%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-07-23
1-Year Low: XX% on 2025-01-25
Most Supportive Themes
- Long-Term Supply Agreement: (60%) A long-term agreement indicates future revenue and stability for Divi's Laboratories.
- Strong Q4 Financial Results: (20%) The financial results from Q4 showed revenue and net profit increases, which can attract investors.
- Bullish Technical Indicators: (20%) Positive technical setups and new highs are in posts, implying bullish sentiment.
Most Critical Themes
- ICICI Securities Downgrade: (2%) ICICI Securities downgraded Divi's Laboratories.
- Reliance on Single Client: (0.5%) Reliance on a single client could lead to price fluctuations.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | X% | X | X% | X | X% | |
| X | XXX | XX% | XXXXX | XX% | XX | X% |
| YouTube | XXX | X% | XXX | XX% | X | X% |
| Total | XXXXX | XX% | XXXXX | XX% | XX | X% |
Market Cap: $undefined #
Market Cap 24-Hour Chart Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXXXX on 2024-12-04
1-Year Low: $XXXXXXXXXXXXXXXXX on 2024-07-23
Top assets mentioned In the posts about Divi's Laboratories Limited in the last XX hours
Novartis AG (NVS) Neogen Corp (NEOG) Morgan Stanley (MS) HDFC Bank Limited (HDB) Microsoft Corp. (MSFT) Wipro Limited (WIT)
Top topics mentioned In the posts about Divi's Laboratories Limited in the last XX hours
india, stocks, $ciplans, investment, aurobindo pharma, $auropharmans, mega, nexus, titan, $aubankbo, nifty50, novartis, $novnsw, stocks healthcare, dr reddys, $torntpharmns, specialized, superior, $neog, reddy, putin, nestle, $nestleindbo, sum, coins energy, $ntpcns, 3m, $trentbo, supreme, $hdfcamcns, asset management, vr, quarterly earnings, privi, vishal, morgan stanley, ecommerce, fsn, dixon technologies, $kalyankjilbo, hcl technologies, apollo hospitals, alltime, teva, ipo, $bhartiartlbo, $hdb, electronics, $akzaas, $zyduslifebo, $mankindbo, market cap, ytshorts, whatsapp, infra, longterm, lo, gmr airports, lockin, pen, tax bracket, nifty, stockmarket, momentum, rsi, sharma, coins healthcare, pradesh, remus, asm, pricing, hint, microsoft, $oberoirltybo, $itcbo, acquisition, jio financial, exchanges, mahindra, $techmbo, wit wipro limited, dd, losses, financial planner
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"2025 T-BLOCK SAFETY SKIT (DIVIS369) IN DIVIS LABORATORIES"
@galinagaraju1478 on YouTube 2025-07-20 18:06:06 UTC XXX followers, XX engagements
"DIVIS LABORATORIES LATEST NEWS II DIVISLAB EXPERTS VIEW TO KNOW WATCH NOW 👆👆👆👆👆👆😱😱😱😱"
@truetrade697 on YouTube 2025-07-20 13:43:22 UTC 4040 followers, XX engagements
"DIVISLAB SHARE PRICE DIVISLAB SHARE LATEST NEWS TODAY Divi's Laboratories SHARE JULY TARGET"
@smitsyt on YouTube 2025-07-20 11:09:15 UTC 6000 followers, XX engagements
"The X Indian CDMO companies rated 'Buy' are: X. Divi's Laboratories: API & custom synthesis leader XX% FY25 revenue growth expanding peptides & Kakinada facility. X. Aurobindo Pharma: Generics & API maker X% FY25 revenue growth targeting biosimilars & Europe expansion. X. Acutaas Chemicals: Specialty chemicals firm XX% FY25 revenue jump focusing on pharma intermediates & electrolytes. X. Blue Jet Healthcare: Specialty CDMO XX% FY25 revenue rise tracking XX new opportunities in contrast media & sweeteners. X. Syngene International: CRAMS provider X% FY25 revenue growth investing in biologics &"
@grok on X 2025-07-20 06:52:39 UTC 5.2M followers, XX engagements